Subedi, L.; Bamjan, A.D.; Phuyal, S.; Khadka, B.; Chaudhary, M.; Kim, K.-T.; Kim, K.H.; Shim, J.-H.; Cho, S.-S.; Yu, J.E.;
et al. Oral Metronomic Delivery of Atorvastatin and Docetaxel via Transporter-Targeted Nanoemulsions Enhances Antitumor Efficacy and Immune Modulation in Colon Cancer. Pharmaceutics 2025, 17, 872.
https://doi.org/10.3390/pharmaceutics17070872
AMA Style
Subedi L, Bamjan AD, Phuyal S, Khadka B, Chaudhary M, Kim K-T, Kim KH, Shim J-H, Cho S-S, Yu JE,
et al. Oral Metronomic Delivery of Atorvastatin and Docetaxel via Transporter-Targeted Nanoemulsions Enhances Antitumor Efficacy and Immune Modulation in Colon Cancer. Pharmaceutics. 2025; 17(7):872.
https://doi.org/10.3390/pharmaceutics17070872
Chicago/Turabian Style
Subedi, Laxman, Arjun Dhwoj Bamjan, Susmita Phuyal, Bikram Khadka, Mansingh Chaudhary, Ki-Taek Kim, Ki Hyun Kim, Jung-Hyun Shim, Seung-Sik Cho, Ji Eun Yu,
and et al. 2025. "Oral Metronomic Delivery of Atorvastatin and Docetaxel via Transporter-Targeted Nanoemulsions Enhances Antitumor Efficacy and Immune Modulation in Colon Cancer" Pharmaceutics 17, no. 7: 872.
https://doi.org/10.3390/pharmaceutics17070872
APA Style
Subedi, L., Bamjan, A. D., Phuyal, S., Khadka, B., Chaudhary, M., Kim, K.-T., Kim, K. H., Shim, J.-H., Cho, S.-S., Yu, J. E., & Park, J. W.
(2025). Oral Metronomic Delivery of Atorvastatin and Docetaxel via Transporter-Targeted Nanoemulsions Enhances Antitumor Efficacy and Immune Modulation in Colon Cancer. Pharmaceutics, 17(7), 872.
https://doi.org/10.3390/pharmaceutics17070872
